1. Home
  2. PRM vs IMCR Comparison

PRM vs IMCR Comparison

Compare PRM & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRM
  • IMCR
  • Stock Information
  • Founded
  • PRM 2018
  • IMCR 2008
  • Country
  • PRM United States
  • IMCR United Kingdom
  • Employees
  • PRM N/A
  • IMCR N/A
  • Industry
  • PRM Newspapers/Magazines
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PRM Consumer Discretionary
  • IMCR Health Care
  • Exchange
  • PRM Nasdaq
  • IMCR Nasdaq
  • Market Cap
  • PRM 1.5B
  • IMCR 1.5B
  • IPO Year
  • PRM N/A
  • IMCR 2021
  • Fundamental
  • Price
  • PRM $11.61
  • IMCR $28.40
  • Analyst Decision
  • PRM Strong Buy
  • IMCR Buy
  • Analyst Count
  • PRM 2
  • IMCR 11
  • Target Price
  • PRM $16.00
  • IMCR $59.11
  • AVG Volume (30 Days)
  • PRM 879.7K
  • IMCR 259.4K
  • Earning Date
  • PRM 05-08-2025
  • IMCR 05-07-2025
  • Dividend Yield
  • PRM N/A
  • IMCR N/A
  • EPS Growth
  • PRM N/A
  • IMCR N/A
  • EPS
  • PRM 0.90
  • IMCR N/A
  • Revenue
  • PRM $573,954,000.00
  • IMCR $333,581,000.00
  • Revenue This Year
  • PRM N/A
  • IMCR $20.26
  • Revenue Next Year
  • PRM $4.89
  • IMCR $8.49
  • P/E Ratio
  • PRM $12.92
  • IMCR N/A
  • Revenue Growth
  • PRM 70.16
  • IMCR 25.75
  • 52 Week Low
  • PRM $7.00
  • IMCR $23.15
  • 52 Week High
  • PRM $14.44
  • IMCR $62.22
  • Technical
  • Relative Strength Index (RSI)
  • PRM 67.52
  • IMCR 45.68
  • Support Level
  • PRM $10.23
  • IMCR $27.88
  • Resistance Level
  • PRM $10.68
  • IMCR $31.38
  • Average True Range (ATR)
  • PRM 0.38
  • IMCR 1.60
  • MACD
  • PRM 0.16
  • IMCR -0.08
  • Stochastic Oscillator
  • PRM 86.92
  • IMCR 22.19

About PRM Perimeter Solutions SA

Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: